Vaxxinity, Inc. (VAXX) Stock Forecast
VAXX analyst forecast
as of October 21, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $15.00 average of analyst targets
- Upside to target
- +14,999,900.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.00
VAXX analyst ratings
1 analystsNumber of analysts at each rating.
VAXX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VAXX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VAXX beat in 11 of 12.
What analysts expect from VAXX
1 analysts cover Vaxxinity; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $15.00, 14,999,900.0% above the latest close of $0.00. Vaxxinity beat the EPS estimate in 11 of the last 12 quarters.
Related: VAXX income statement, VAXX key metrics, VAXX chart. See the VAXX stock overview for the latest quote and news.
VAXX forecast FAQ
What is Vaxxinity's price target?
The average analyst price target for Vaxxinity is $15.00, 14,999,900.0% above the latest close of $0.00.
Is Vaxxinity a buy, hold or sell?
Of 1 analysts covering Vaxxinity, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
Does Vaxxinity usually beat earnings estimates?
Vaxxinity reported EPS at or above the analyst estimate in 11 of the last 12 quarters.